1823, Vol. I
|Edited by||Richard Horton|
The journal was founded in 1823 by Thomas Wakley, an English surgeon who named it after the surgical instrument called a lancet (scalpel), as well as after the architectural term lancet window, a window with a sharp pointed arch, to indicate the "light of wisdom" or "to let in light".
The journal publishes original research articles, review articles ("seminars" and "reviews"), editorials, book reviews, correspondence, as well as news features and case reports. The Lancet has been owned by Elsevier since 1991, and its editor-in-chief since 1995 is Richard Horton. The journal has editorial offices in London, New York, and Beijing.
According to the Journal Citation Reports, the journal has a 2018 impact factor of 59.102, ranking it second after The New England Journal of Medicine in the category "Medicine, General & Internal".
The Lancet also publishes several specialty journals: The Lancet Neurology (neurology), The Lancet Oncology (oncology), The Lancet Infectious Diseases (infectious diseases), The Lancet Respiratory Medicine (respiratory medicine), The Lancet Psychiatry (psychiatry), The Lancet Diabetes and Endocrinology (endocrinology), and The Lancet Gastroenterology & Hepatology (Gastroenterology) all of which publish original research and reviews. In 2013, The Lancet Global Health (global health) became the group's first fully open access journal. In 2014, The Lancet Haematology (haematology) and The Lancet HIV (infectious diseases) were launched, both as online only research titles. The Lancet Child & Adolescent Health (paediatrics) launched in 2017. The three established speciality journals (The Lancet Neurology, The Lancet Oncology, and The Lancet Infectious Diseases) have built up strong reputations in their medical speciality. According to the Journal Citation Reports, The Lancet Oncology has a 2017 impact factor of 36.421, The Lancet Neurology has 27.144, and The Lancet Infectious Diseases has 25.148. There is also an online website for students entitled The Lancet Student in blog format, launched in 2007.
Prior to 1990, The Lancet had volume numbering that reset every year. Issues in January to June were in volume i, with the rest in volume ii. In 1990, the journal moved to a sequential volume numbering scheme, with two volumes per year. Volumes were retro-actively assigned to the years prior to 1990, with the first issue of 1990 being assigned volume 335, and the last issue of 1989 assigned volume 334. The table of contents listing on ScienceDirect uses this new numbering scheme.
This section appears to be slanted towards recent events. (January 2016) (Learn how and when to remove this template message)
The Lancet has taken a political stand on several important medical and non-medical issues. Recent examples include criticism of the World Health Organization (WHO), rejection of the WHO's claims of the efficacy of homoeopathy as a therapeutic option, disapproval during the time Reed Exhibitions (a division of Reed Elsevier) hosted arms industry fairs, a call in 2003 for tobacco to be made illegal, and a call for an independent investigation into the American bombing of a hospital in Afghanistan in 2015.
Andrew Wakefield and the MMR vaccine (1998)Edit
The Lancet was criticised after it published a paper in 1998 in which the authors suggested a link between the MMR vaccine and autism spectrum disorder. In February 2004, The Lancet published a statement by 10 of the paper's 13 coauthors repudiating the possibility that MMR could cause autism. The editor-in-chief, Richard Horton, went on the record to say the paper had "fatal conflicts of interest" because the study's lead author, Andrew Wakefield, had a serious conflict of interest that he had not declared to The Lancet. The journal completely retracted the paper on 2 February 2010, after Wakefield was found to have acted unethically in conducting the research.
The Lancet's six editors, including the editor-in-chief, were also criticised in 2011 because they had "covered up" the "Wakefield concocted fear of MMR" with an "avalanche of denials" in 2004.
Tobacco ban proposal (2003)Edit
A December 2003 editorial by the journal, titled "How do you sleep at night, Mr Blair?", called for tobacco use to be completely banned in the UK. The Royal College of Physicians rejected their argument. John Britton, chairman of the college's tobacco advisory group, praised the journal for discussing the health problem, but he concluded that a "ban on tobacco would be a nightmare." Amanda Sandford, spokesperson for the anti-tobacco group Action on Smoking and Health, stated that criminalising a behaviour 26% of the population commit "is ludicrous." She also said: "We can't turn the clock back. If tobacco were banned we would have 13 million people desperately craving a drug that they would not be able to get." The deputy editor of The Lancet responded to the criticism by arguing that no other measures besides a total ban would likely be able to reduce tobacco use.
The smokers rights group FOREST stated that the editorial gave them "amusement and disbelief". Director Simon Clark called the journal "fascist" and argued that it is hypocritical to ban tobacco while allowing unhealthy junk foods, alcohol consumption, and participation in extreme sports. Health Secretary John Reid reiterated that his government was committed to helping people give up smoking. He added: "Despite the fact that this is a serious problem, it is a little bit extreme for us in Britain to start locking people up because they have an ounce of tobacco somewhere."
Iraq War death toll controversy (2004)Edit
The Lancet also published a controversial estimate of the Iraq War's Iraqi death toll—around 100,000—in 2004. In 2006, a follow-up study by the same team suggested that the violent death rate in Iraq was not only consistent with the earlier estimate, but had increased considerably in the intervening period (see Lancet surveys of casualties of the Iraq War). The second survey estimated that there had been 654,965 excess Iraqi deaths as a consequence of the war. The 95% confidence interval was 392,979 to 942,636. 1,849 households that contained 12,801 people were surveyed.
The estimates provided in the second article are much higher than those published in other surveys from the same time. Most notably, the "Iraq Family Health Survey" published in the New England Journal of Medicine surveyed 9,345 households across Iraq and estimated 151,000 deaths due to violence (95% uncertainty range, 104,000 to 223,000) over the same period covered in the second Lancet survey by Burnham et al. The NEJM article stated that the second Lancet survey "considerably overestimated the number of violent deaths" and said the Lancet results were "highly improbable, given the internal and external consistency of the data and the much larger sample size and quality-control measures taken in the implementation of the IFHS."
Fabricated articles withdrawn (2006)Edit
In January 2006, it was revealed that data had been fabricated in an article by the Norwegian cancer researcher Jon Sudbø and 13 co-authors published in The Lancet in October 2005. Several articles in other scientific journals were withdrawn following the withdrawal in The Lancet. Within a week, the New England Journal of Medicine published an expression of editorial concern regarding its published research papers by the same author, and in November 2006, the journal withdrew two oral cancer studies led by the Norwegian researcher.
In August 2010, The Lancet Infectious Diseases published an article about an enzyme conferring multi-drug-resistance properties in bacteria, which had previously been named New Delhi metallo-beta-lactamase or NDM-1 based on the assumed origin of the mechanism. The article reported 44 clinical isolates of bacteria positive for NDM-1 from Chennai, 26 from Haryana, 37 (from 29 patients) from the UK, and 73 from other sites in India, Pakistan, and Bangladesh. Of the 29 UK patients, 17 had a history of travel to India or Pakistan within 1 year, and 14 had been admitted to hospital in these countries. The authors of the article cited medical tourism to India for the spread of bacteria carrying NDM-1, which the Indian government denied.
Health impact of alcohol (2010)Edit
A December 2010 article determined that alcohol had the worst medical and social effects compared to other recreational substances such as heroin and crack cocaine. The drugs marijuana, ecstasy, and LSD scored far lower in terms of related harms. The authors did not advocate alcohol prohibition, but they suggested that the government raise the price of alcohol until it was no longer widely available. Gavin Partington of the Wine and Spirit Trade Association, responded to the report by saying that alcohol abuse affects "a minority" needing "education, treatment and enforcement". He also remarked that millions of British citizens enjoy alcohol as "a regular and enjoyable social drink".
PACE study (2011)Edit
In 2011, The Lancet published a study by the UK-based "PACE trial management group", which reported success with graded exercise therapy and cognitive behavioural therapy for chronic fatigue syndrome; a follow-up study was published in Lancet Psychiatry in 2015. The studies attracted criticism from some patients and researchers, especially with regard to data analysis that was different from that described in the original protocol. In a 2015 Slate article, biostatistician Bruce Levin of Columbia University was quoted saying "The Lancet needs to stop circling the wagons and be open", and that "one of the tenets of good science is transparency"; while Ronald Davis of Stanford University said: "the Lancet should step up to the plate and pull that paper". Horton defended The Lancet's publication of the trial and called the critics: "a fairly small, but highly organized, very vocal and very damaging group of individuals who have, I would say, actually hijacked this agenda and distorted the debate so that it actually harms the overwhelming majority of patients."
Starting in 2011, critics of the studies filed Freedom of Information Act requests to get access to the authors' primary data, in order to learn what the trial's results would have been under the original protocol. In 2016, some of the data was released, which allowed calculation of results based on the original protocol and found that additional treatment led to no significant improvement in recovery rates over the control condition.
Open Letter for the People of Gaza (2014)Edit
In August 2014 and during the 2014 Israel–Gaza conflict, The Lancet published an "Open letter for the people of Gaza" in their correspondence section. As reported in The Daily Telegraph, the letter "condemned Israel in the strongest possible terms, but strikingly made no mention of Hamas' atrocities." According to Haaretz, the authors of the letter include doctors who "are apparently sympathetic to the views of David Duke, a white supremacist and former Ku Klux Klan Grand Wizard." One of the doctors responded by saying: "I legitimately use my right of freedom of opinion and do not agree or value the politics of the government of Israel, nor of many others, including Jews in and out of Israel." A second one responded with: "I didn't know who David Duke was, or that he was connected to the Ku Klux Klan. I am concerned that if there is any truth in the video, that Jews control the media, politics and banking, what on earth is going on? I was worried."
The editor of The Lancet, Richard Horton, said: "I have no plans to retract the letter, and I would not retract the letter even if it was found to be substantiated." However, Horton subsequently came to Israel's Rambam Hospital for a visit and said that he "deeply, deeply regret[ted] the completely unnecessary polarization that publication of the letter by Paola Manduca caused."
Mark Pepys, a member of the Jewish Medical Association, wrote: “The failure of the Manduca et al. authors to disclose their extraordinary conflicts of interest... are the most serious, unprofessional and unethical errors. The transparent effort to conceal this vicious and substantially mendacious partisan political diatribe as an innocent humanitarian appeal has no place in any serious publication, let alone a professional medical journal, and would disgrace even the lowest of the gutter press." In addition, Pepys accused Richard Horton personally, saying: "Horton's behavior in this case is consistent with his longstanding and wholly inappropriate use of The Lancet as a vehicle for his own extreme political views. It has greatly detracted from the former high standing of the journal." In response, Horton said: "How can you separate politics and health? The two go hand-in-hand."
Study on hydroxychloroquine (2020)Edit
On 22 May 2020, The Lancet published an article by Mehra et al, "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis". This study, based on retrospective observational review of 96,032 patients from 671 hospitals between 20 December 2019 and 14 April 2020, had an immediate impact; the WHO decided to stop all the clinical trials on hydroxychloroquine.
On 26 May 2020, Australian researchers found an error: only 67 deaths from COVID-19 had been recorded in Australia by 21 April, where the study claims 73. The Lancet told Guardian Australia, "We have asked the authors for clarifications, we know that they are investigating urgently, and we await their reply." Surgisphere's Sapan Desai said a hospital from Asia had accidentally been included in the Australian data.
On 28 May some 180 researchers and doctors from various countries published An open letter to Richard Horton, editor of The Lancet, regarding Mehra et al. The following day, The Lancet published a corrected version. According to the authors, the corrections did not change the overall findings of no benefit. However, on 2 June 2020, The Lancet published an "Expression of Concern" and began an independent audit commissioned by the authors.
On 3 June 2020, the WHO announced that clinical trials of Hydroxychloroquine or chloroquine will be continued. The following day, three of the four authors retracted the paper, and The Lancet published a retraction of the study.
In June 2020 a WHO-funded study claimed a reduction from 2 metres to 1 metre social distancing would raise infection risk from 1.3% to 2.6%. Prof Ben Cowling of the WHO Collaborating Centre for Infectious Disease Epidemiology and Control at the University of Hong Kong was critical of the study because it looked only at distance and not how long a person was exposed for. The UK Governments paper, Environmental influence on transmission of COVID-19, 28 April 2020, takes into account how long people are together, ventilation and room size. The WHO-funded research was carried out by a team at McMaster University in Ontario. The McMaster team pooled data from previously published studies to estimate the risk of becoming infected with coronavirus at different distances. Kevin McConway, emeritus professor of applied statistics at the Open University said, “The method of comparing the different distances in the paper is inappropriate for telling you exactly how the risk at 2-metre minimum distance compares to a 1 metre minimum distance. It does not support, and should not be used in, arguments about how much greater the risk is with a 1 metre limit versus a 2-metre limit.” Other critics of the report include David Spiegelhalter, Winton Professor of the Public Understanding of Risk at Cambridge University, and member of the UK government’s Scientific Advisory Group for Emergencies. The WHO responded by saying, "The evidence used to inform this guidance was based on a systematic review of all available, relevant observational studies concerning protective measures to prevent transmission of the coronaviruses that cause Sars, Mers and Covid-19. After checking for relevance, 44 comparative studies done in health-care and non-health-care settings were included." The Lancet report was published as Boris Johnson, the UK Prime Minister, launched a review into the 2m social distancing rule. UK government scientific advisers report that being 1m apart carries up to 10 times the risk of being 2m apart.
Comments on the Trump administration (2020)Edit
On 16 May 2020, The Lancet published an article on the US Centers for Disease Control (CDC) that, amongst other things, faulted the Trump administration for its July 2019 termination of a CDC programme under which the CDC stationed officers in China, ostensibly to serve as a distant early warning system. The writers opined that CDC director Robert R. Redfield was frightened of Trump and in any case had not "the technical capacity to lead today's complicated effort." The article concluded with a call to the American people to elect someone other than Trump in November 2020.
List of editorsEdit
The following persons have been editors-in-chief of the journal:
- "Prestigious Medical Journal, The Lancet, Issues Family Planning Series". Population Media Center. 13 July 2012. Retrieved 4 March 2014.
- "Scholar Metrics: Top Publications". Google Scholar.
- "About the Lancet". Retrieved 23 April 2020.
- "People at The Lancet". The Lancet. Retrieved 14 November 2018.
- "Journals Ranked by Impact: Medicine, General". 2018 Journal Citation Reports. Web of Science (Science ed.). Clarivate Analytics. 2018.
- The Lancet. Science Direct.
- "Homoeopathy's benefit questioned". BBC News. 26 August 2005. Archived from the original on 15 May 2018.
- Ferriman A (2003). "Lancet calls for tobacco to be made illegal". BMJ. 327 (7428): 1364. doi:10.1136/bmj.327.7428.1364-b. PMC 293016.
- What are the Geneva Conventions for?, editorial, The Lancet, vol. 386, no. 10003, p. 1510, 17 October 2015
- Lyall J (2004). "Editor in the eye of a storm". British Medical Journal. 328 (7438): 528. doi:10.1136/bmj.328.7438.528. PMC 351866. PMID 15164721.
- Murch SH, Anthony A, Casson DH, Malik M, Berelowitz M, Dhillon AP, Thomson MA, Valentine A, Davies SE, Walker-Smith JA (March 2004). "Retraction of an interpretation". Lancet. 363 (9411): 750. doi:10.1016/S0140-6736(04)15715-2. PMID 15016483. S2CID 5128036.
- "MMR researchers issue retraction". BBC News. 4 March 2004. Archived from the original on 12 April 2016.
- Park, Madison (2 February 2010). "Medical journal retracts study linking autism to vaccine". CNN. Archived from the original on 27 May 2013.
- Deer, Brian (19 January 2011). "The Lancet's two days to bury bad news". Archived from the original on 23 February 2014. Retrieved 18 November 2014.
Were it not for the GMC case, which cost a rumored £6m (€7m; $9m), the fraud by which Wakefield concocted fear of MMR would forever have been denied and covered up.
- Laurance, Jeremy (5 December 2003). "Lancet calls for tobacco ban to save thousands of lives". The Independent. Archived from the original on 6 June 2011. Retrieved 18 January 2010.
- "UK ministers urged to ban tobacco". BBC News. 5 December 2003. Archived from the original on 10 April 2016. Retrieved 18 January 2010.
- Coghlan, Ben (30 October 2006). "Gut reaction aside, those on the ground know Iraq reality". Eureka Street. Archived from the original on 28 May 2018.
- Sudbø J, Lee JJ, Lippman SM, et al. (2005). "Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study". The Lancet. 366 (9494): 1359–66. doi:10.1016/S0140-6736(05)67488-0. PMID 16226613. S2CID 7679747. (Retracted)
- "Cancer study patients 'made up'". BBC News. 16 January 2006. Archived from the original on 4 February 2012.
- Hafstad, Anne (17 January 2006). "Største svindel verden har sett". Aftenposten (in Norwegian). Archived from the original on 24 October 2008.
- Cortez, Michelle Fay (1 November 2006). "Medical Journal Retracts Oral Cancer Studies Linked to Fraud". Bloomberg News. Archived from the original on 20 July 2012.
- Kumarasamy KK, Toleman MA, Walsh TR, et al. (2010). "Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study". The Lancet Infectious Diseases. 10 (9): 597–602. doi:10.1016/S1473-3099(10)70143-2. PMC 2933358. PMID 20705517.
- Yong D, Giske CG, Toleman M, Walsh TR (28 October 2008). "A novel subgroup metallo-B-lactamase (MBL), NDM-1 emerges in Klebsiella pneumoniae (KPN) from India". 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, USA. pp. C1–105.
- Yong D, Toleman MA, Giske CG, et al. (2009). "Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India" (PDF). Antimicrobial Agents and Chemotherapy. 53 (12): 5046–5054. doi:10.1128/AAC.00774-09. PMC 2786356. PMID 19770275.
- "MNCs behind superbug propaganda: Ahluwalia". Hindustan Times. Indo-Asian News Service. 12 August 2010. Archived from the original on 14 August 2010. Retrieved 16 August 2010.
- "Researchers dismiss superbug controversy". Sify News. Asian News International. 14 August 2010. Archived from the original on 11 August 2011. Retrieved 18 November 2014.
- Cheng, Maria (1 November 2010). "Study: Alcohol more lethal than heroin, cocaine". Boston.com. Associated Press. Archived from the original on 2 March 2017.
- "Alcohol 'more harmful than heroin' says Prof David Nutt". BBC News. 1 November 2010. Archived from the original on 10 May 2017.
- White PD, et al. (2011). "Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial". The Lancet. 377 (9768): 823–836. doi:10.1016/S0140-6736(11)60096-2. PMC 3065633. PMID 21334061.
- Sharpe, M; Goldsmith, KA; Johnson, AL; Chalder, T; Walker, J; White, PD (December 2015). "Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial" (PDF). The Lancet Psychiatry. 2 (12): 1067–74. doi:10.1016/s2215-0366(15)00317-x. PMID 26521770.
- Rehmeyer, Julie (13 November 2015). "Hope for Chronic Fatigue Syndrome: The debate over this mysterious disease is suddenly shifting". Slate. Archived from the original on 15 August 2019.
- Wilshire, C; Kindlon, T; Matthees, A; McGrath, S (2016). "Can patients with chronic fatigue syndrome really recover after graded exercise or cognitive behavioural therapy? A critical commentary and preliminary re-analysis of the PACE trial". Fatigue: Biomedicine, Health & Behavior. 5 (1): 43–56. doi:10.1080/21641846.2017.1259724.
- Rehmeyer, Julie; Tuller, David (18 March 2017). "Getting It Wrong on Chronic Fatigue Syndrome". The New York Times (editorial). Archived from the original on 28 October 2019.
- Manduca, Paolo; et al. (2014). "An open letter for the people in Gaza". The Lancet. 384 (9941): 397–398. doi:10.1016/S0140-6736(14)61044-8. PMID 25064592. S2CID 4672171. Retrieved 1 February 2017.
- Simons, Jake Wallis (22 September 2014). "Lancet 'hijacked in anti-Israel campaign'". The Daily Telegraph. London. Archived from the original on 23 February 2018. Retrieved 2 October 2014.
- "British medical journal refuses to retract 'letter to Gaza' by anti-Semitic activists". Haaretz. Tel Aviv. 22 September 2014. Archived from the original on 21 January 2015. Retrieved 2 October 2014.
- Lazareva, Inna (3 October 2014). "Lancet editor apologises for Gaza article by scientists who promoted Ku Klux Klan". The Daily Telegraph. London. Archived from the original on 25 May 2018. Retrieved 5 October 2014.
- "In Israel, Lancet editor regrets publishing open letter on Gaza". Haaretz. Tel Aviv. Jewish Telegraphic Agency. 3 October 2014. Archived from the original on 26 June 2018. Retrieved 5 October 2014.
- Siegel-Itzkovich, Judy (2 October 2014). "The Lancet editor relents on medical journal's unbalanced attacks on Israel". The Jerusalem Post. Archived from the original on 28 May 2015. Retrieved 5 October 2014.
- "Lancet editor in editorial regrets, but does not retract, Gaza letter". Jewish Telegraphic Agency. 12 October 2014. Archived from the original on 12 October 2019.
- "Lancet Editor Richard Horton "Regrets" Gaza Letter's "Polarization"". NGO Monitor. 2 October 2014. Archived from the original on 19 September 2017.
- Mehra MR, Desai SS, Ruschitzka F, Patel AN, et al. (2020). "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis". The Lancet Infectious Diseases.
- Vera, Amir; Howard, Jacqueline (25 May 2020). "WHO temporarily pauses hydroxychloroquine study due to safety concerns". CNN.
- Davey, Melissa (28 May 2020). "Questions raised over hydroxychloroquine study which caused WHO to halt trials for Covid-19". The Guardian.
- An open letter to Richard Horton, editor of The Lancet regarding Mehra et al.
- Mehra MR, Desai SS (30 May 2020). "Department of Error". The Lancet Infectious Diseases.
- Hopkins, Jared S. (29 May 2020). "Medical Journal Issues Correction on Study of Covid-19 and Antimalarial Drugs". Wall Steet Journal.
- "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis". Expression of concern. The Lancet Infectious Diseases. 2 June 2020.
- Mehra MR, Ruschitzka F, Patel AN (June 2020). "Retraction: "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis"". Lancet. 395 (10240): 1820. doi:10.1016/S0140-6736(20)31324-6. PMID 32511943.
- "Retraction: "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis"". The Lancet. 4 June 2020. Retrieved 4 June 2020.
- Boseley S, Davey M (4 June 2020). "Covid-19: Lancet retracts paper that halted hydroxychloroquine trials". The Guardian. Retrieved 4 June 2020.
- Chu, Derek; Akl, Elie; Duda, Stephanie; Sally Yaacoub, Karla; Yaacoub, Sally; Schünemann, Holger (1 June 2020). "Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis". The Lancet. 395 (10242): 1973–1987. doi:10.1016/S0140-6736(20)31142-9. PMID 32497510. Retrieved 15 June 2020.
- "Environmental influence on transmission of COVID-19, 28 April 2020". UK Government. UK Government (SAGE). 28 April 2020. Retrieved 15 June 2020.
- Sample, Ian (14 June 2020). "Scientists report flaws in WHO-funded study on 2-metre distancing". The Guardian. Retrieved 15 June 2020.
- "Coronavirus: Boris Johnson launches review into 2m social distancing rule". BBC News. 14 June 2020. Retrieved 15 June 2020.
- Shukman, David (14 June 2020). "Coronavirus: Could social distancing of less than two metres work? =BBC News online". Retrieved 15 June 2020.
- The Lancet (16 May 2020). "Reviving the US CDC". The Lancet. 395 (10236): 1521. doi:10.1016/S0140-6736(20)31140-5. PMC 7255307. PMID 32416772.
- Ensor, Josie (15 May 2020). "The Lancet urges Americans to vote out Trump over coronavirus handling". Telegraph Media Group Limited.